Benitec Biopharma
BNTC
BNTC
13 hedge funds and large institutions have $3.9M invested in Benitec Biopharma in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$53.9K |
| 2 |
2
Morgan Stanley
New York
|
$32.9K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$8.06K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$2.01K |
| 5 |
GI
5
GAMMA Investing
Foster City,
California
|
$947 |
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$0 |
| 2 |
2
Janus Henderson Group
London,
United Kingdom
|
$589K |
| 3 |
MHR
3
Matthew Hamilton Rosenberg
|
$0 |
